期刊文献+

亚胺培南耐药鲍曼不动杆菌小鼠肺部感染模型建立 被引量:7

Establishment of mice pneumonia model with imipenem-resistant Acinetobacter baumannii
原文传递
导出
摘要 目的 建立亚胺培南耐药鲍曼不动杆菌小鼠肺部模型,为泛耐药鲍曼不动杆菌抗感染研究提供实验动物模型.方法 随机选取120只约4周大雄性BALB/C小鼠,平均分成3组:微量气管注射法组、超声雾化法组和滴鼻法组.每组小鼠用甲氨蝶呤化疗降低BALB/C小鼠的免疫力,然后将亚胺培南耐药鲍曼不动杆菌分别用微量气管注射法、超声雾化法、滴鼻法感染免疫力低下和正常的BALB/C小鼠,检测微量气管注射法、超声雾化法、滴鼻法感染的小鼠感染率、死亡率、细菌清除率、肺部病理变化.结果 微量气管注射法、超声雾化法感染免疫力低下的BALB/C小鼠的肺部感染率均为100%(30/30),死亡率分别为100%(10/10),33%(3/10),2组小鼠肺部细菌感染12~24 h后支气管周及肺泡间质内见中性粒细胞、淋巴细胞、巨噬细胞为主的炎症细胞浸润,微量气管注射法感染的小鼠部分肺泡组织结构崩解,肺泡腔内可见脓肿形成及较多细菌集落,超声雾化法感染的小鼠24 h见肺部部分区域存在细胞变性,但支气管及肺泡组织结构基本正常,肺泡壁血管轻度扩张伴淤血,24~48 h后可见支气管和支气管周围变性,部分肺组织血管高度扩张,伴有水肿,48 h后炎症逐渐恢复.滴鼻法感染免疫力低下的BALB/C小鼠的肺部感染不明显,未见小鼠死亡(0/10),肺部无明显病理变化.结论 免疫力低下BALB/C小鼠可以通过微量气管注射法和超声雾化法建立亚胺培南耐药鲍曼不动杆菌肺部感染模型,超声雾化法可以大批量同时操作,简单经济快速,实用性强.亚胺培南耐药鲍曼不动杆菌难以感染免疫力正常小鼠. Objective To construct the mice pneumonia model with imipenem-resistant Acinetobacter baumannii and provide experimental model in anti-pan-resistant Acinetobacter baumannii therapy study. Methods A total number of 120 4-week-old BALB/C male mice were randomly selected and divided into three groups including micro-intratracheal injection, ultrasonic atomizing and nasal dripping. The mice were treated with methotrexate to induce hypo-immunity in every group. These BALB/C mice of normal immunity and hypo-immunity were infected through Imipenem-resistant Acinetobacter baumannii by microintratracheal injection, ultrasonic atomizing and nasal dripping, respectively. The morbidity, mortality,bacterial clearance rate and histopathology in lung were determined. Results The morbidities of BALB/C mice with hypo-immunity infected by micro-intratracheal injection and ultrasonic atomizing achieved 100%(30/30), while the mortalities were 100% (10/10) and 33.3% (3/10), respectively. Mice in two groups above displayed the influx of neutrophils, lymphocytes and macrophages in the peri-bronchial and alveolar interstitial space 12-24 h after pulmonary infection. In addtion, the mice in micro-intratracheal injection group displayed coUapse of partial alveolar walls, formation of abscesses and bacterial colonies in alveoli. While the lung pathology in mice of ultrasonic atomizing group was characterized by cell degeneration in some regions in the lungs, slight relaxation, congestion in alveolar wall vessels and normal of bronchial and alveolar tissue 24 h after inoculation. Degeneration in peri-tracheal and peri-bronchial areas was observed 24-48 h after inoculation, along with highly expanded pulmonary blood vessels and edems. The inflammation was reduced at 48 hours. There was no obvious pulmonary infection in BALB/C mice with hypo-immunity by nasal dripping with mortality of 0% (0/10) and no significant histopathologic change in lungs. Conclusions BALB/C mice with hypo-immunity pneumonia model with Imipenem-resistant Acinetobacter baumannii can be conducted by micro-intratracheal injection or ultrasonic atomizing, but the latter has the advantages of high-productivity, easy-operation, low-cost, time-saving and usefulness. Mice with normal immunity are not susceptible to imipenem-resistant Acinetobacter baumannii.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第8期771-775,共5页 Chinese Journal of Laboratory Medicine
基金 国家高技术研究发展计划(863计划)资助项目(2006AA02Z413) 浙江省医药卫生科技计划资助项目(2008A129) 杭州市医药卫生科技计划资助项目(2008A003)
关键词 鲍氏不动杆菌 不动杆菌感染 肺炎 细菌性 疾病模型 动物 亚胺培南 Acinetobacter baumannii Acinetobacter infections Pneumonia,bacterial Disease models,animal Imipenem
  • 相关文献

参考文献9

  • 1Fournier PE,Vallenet D,Barbe V,et al.Comparative genomics of multidrug resistance in Acinetobacter baumannii.PLoS Genet,2006,2:e7.
  • 2Jones A,Morgan D,Walsh A.Importation of multidrug-resistant Acinetobacter spp.infections with casualties from Iraq.Lancet Infect Dis,2006,6:317-318.
  • 3Joly-Guillou ML,Wolff M,Pocidalo JJ,et al.Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.Antimicrob.Agents Chemother,1997,41:345-351.
  • 4Montero A,Ariza J,Corbella X,et al.Efficacy of colistin versus beta-lactams,aminoglycosides,and rifampin asmonotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.Antimicrob.Agents Chemother,2002,46:1946-1952.
  • 5王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 6裘莉佩,潘登,徐炜烽,周华,魏泽庆,俞云松.鲍曼不动杆菌碳青霉烯酶基因型及分子流行病学研究[J].中华流行病学杂志,2007,28(4):381-384. 被引量:28
  • 7Wagenvoort JH,De Brauwer EI,Toenbreker HM,et al.Epidemic Acinetobacter baumannii strain with MRSA-like behaviour carried by healthcare staff.Eur J Clin Microbiol Infect Dis,2002,21:326-327.
  • 8Joly-Guillou ML.Clinical impact and pathogenicity of Acinetobacter.Clin Microbiol Infect,2005,11:868-873.
  • 9van Faassen H,KuoLee R,Harris G,et al.Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.Infect Immun,2007,75:5597-5608.

二级参考文献27

  • 1应春妹,汪雅萍,李菁菁,刘智凯,凌健华.产OXA-23型碳青霉烯水解酶鲍曼不动杆菌基因研究[J].检验医学,2004,19(6):483-486. 被引量:10
  • 2张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71
  • 3王金良.密切注视鲍曼不动杆菌的耐药发展趋势[J].中华检验医学杂志,2005,28(4):355-356. 被引量:194
  • 4王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 5Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
  • 6Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
  • 7Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
  • 8Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
  • 9Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
  • 10Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.

共引文献209

同被引文献65

  • 1赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:82
  • 2徐英春,王贺,孙宏莉,王瑶,谢秀丽,陈民钧.细菌耐药监测让我们走近临床[J].中华检验医学杂志,2007,30(5):485-488. 被引量:31
  • 3Fournier PE,Vallenet D,Barbe V,et al.Comparative genomics of multidrug resistance in Acinetobacter baumannii[J].PLoS Genetics,2006,2:e7.
  • 4Zhou H,Zhang TW,Yu DL,et al.Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China[J].Antimicrob Agents Chemother,2011,55(10):4506-4512.
  • 5Jones A,Morgan D,Walsh A.Importation of multidrug-resistant Acinetobacter spp.infections with casualties from Iraq[J].Lancet Infect Dis,2006,6:317-318.
  • 6Runnegar N, Sidjabat H,Goh HM,et al.Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period[J].J Clin Microbiol,2010,48(11):4051-4056.
  • 7Domenech de Cellès M,Salomon J,Marinier A,et al.Identifying more epidemic clones during a hospital outbreak of multidrug-resistant Acinetobacter baumannii[J].PLoS One,2012,7(9):e45758.
  • 8Kochar M,Crosatti M,Harrison EM,et al.Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain[J].Antimicrob Agents Chemother,2012,56(4):1845-1853.
  • 9McConneI1 MJ, Actis 1., Pachon J. Acinetobacter baumannii : human infections, factors contributing to pathogenesis and animal models[J]. FEMS Microbiol Rev, 2013, 37(2):130 155.
  • 10Knapp S, Wieland CW, Florquin S, et al. Differential roles of CD14 and toll like receptors 4 and 2 in murine Acinetobacter pneurnonia[J]_. Am J Respir Crit Care Med, 2006, 173(1):122 129.

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部